Filing Details
- Accession Number:
- 0001209191-20-064430
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 16:34:08
- Reporting Period:
- 2020-08-06
- Accepted Time:
- 2020-12-18 16:34:08
- Original Submission Date:
- 2020-08-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1237831 | Globus Medical Inc | GMED | Surgical & Medical Instruments & Apparatus (3841) | 043744954 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555392 | M David Demski | Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2020-08-06 | 173,750 | $29.31 | 322,605 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2020-08-06 | 96,875 | $43.77 | 419,480 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2020-08-06 | 59,375 | $43.58 | 478,855 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-08-06 | 96,900 | $55.42 | 381,955 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-08-06 | 68,100 | $56.24 | 313,855 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-08-06 | 165,000 | $57.02 | 148,855 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The Form 4 filed on August 10, 2020 inadvertently excluded 148,855 shares of Class A Common Stock owned directly by the Reporting Person, and Column 5 has been amended to reflect such shares.
- This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.995, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.97, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
Billionaire Hedge Funds
